{"data":{"id":"us/48-cfr-27.204-1","jurisdiction":"us","citation":"48 CFR 27.204-1","heading":"27.204-1 Use of patented technology under the United States-Mexico-Canada Agreement.","body":"When questions arise with regard to use of patented technology under the United States-Mexico-Canada Agreement, the contracting officer should consult with legal counsel. Note that Article 20.6(a) of the Agreement discusses public health and pharmaceuticals.","path":["Title 48—Federal Acquisition Regulations System","CHAPTER 1—FEDERAL ACQUISITION REGULATION","SUBCHAPTER E—GENERAL CONTRACTING REQUIREMENTS","PART 27—PATENTS, DATA, AND COPYRIGHTS","Subpart 27.2—Patents and Copyrights"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-48.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:26:29Z","sha256":"8ce5491957856a540ae5ca8033d878a9f142890901428c04ca264b6193387cbe","source_id":"us-cfr","stale":true,"prev":"us/48-cfr-27.204","next":"us/48-cfr-27.204-2"},"notice":"GroundRules: Original legal text. Not legal advice."}